MASLD develops from excessive accumulation of fat in the liver which results from metabolic disorders, not alcohol consumption. The condition causes fatigue and upper abdominal discomfort in some individuals while others remain asymptomatic until they receive routine medical tests. The worldwide population of people with MASLD affects millions, causing severe liver damage when it remains untreated.
People who face higher risk of developing MASLD tend to have obesity, type 2 diabetes, high cholesterol or insulin resistance. The research team conducts clinical trials to evaluate new medications and lifestyle changes, to see how well they reduce liver fat and slow disease progression while enabling patients to protect their liver health for the long term.
Interested in learning more about participation in our clinical research studies? Determine your eligibility by responding to a brief set of inquiries. By completing the form below, you grant us permission to connect with you via phone, text, or email, offering further details through our research team.
If these health challenges disrupt your daily routine, you might be eligible for a clinical research opportunity. Feel free to reach out by filling out the form provided or giving us a call. Once you've submitted, one of our specialized team members at Biopharma will promptly get in touch with you.